Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Aberrant Crypt Foci × Sulindac × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1 Neoplasms 1 Leukoplakia, Oral 1 Coproporphyria 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Aberrant Crypt Foci 1

Interventions

Sulindac 1 Curcumin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00176618 2009-12-11

The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon

Rutgers, The State University of New Jersey

Phase NA Terminated

Aberrant Crypt Foci

Data powered by HemOnc (CC BY 4.0) Colophon ⚡